Skip to main content

Published locations for MONARCH 1: Abemaciclib is active in refractory HR+, HER2– breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. MONARCH 1: Abemaciclib is active in refractory HR+, HER2– breast cancer

User login

  • Reset your password
  • /content/monarch-1-abemaciclib-active-refractory-hr-her2-breast-cancer
  • /oncologypractice/article/109426/breast-cancer/monarch-1-abemaciclib-active-refractory-hr-her2-breast
  • /hematology-oncology/article/109426/breast-cancer/monarch-1-abemaciclib-active-refractory-hr-her2
  • /breast-cancer-icymi/article/109426/breast-cancer/monarch-1-abemaciclib-active-refractory-hr-her2